IP Library Patent Application 15082722
Patent Application
App. No. 15/082,722

OMEGA-3 PHOSPHOLIPID SUPPLEMENTS FOR IMPROVED BRAIN MATURITY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/082,722
Abstract

The invention relates to omega-3 phospholipid supplements for use in adolescents, and in particular to use omega-3 phospholipid supplements to improve or support brain maturity age. In preferred embodiments, the omega-3 phospholipid is krill oil.

Claims (22)

1 . A method of improving or supporting brain maturity age in a subject in need thereof comprising:

administering an omega-3 phospholipid supplement to said subject under conditions such that the brain maturity age of the subject is improved.

2 . The method of claim 1 , wherein said omega-3 phospholipid supplement is a krill oil, fish oil, fish roe oil, or fish byproduct oil.

3 . The method of claim 2 , wherein said krill oil comprises from about 35% to 60% phospholipids on a w/w basis; from about 20% to 45% triglycerides on a w/w basis; and from about 50 to about 2500 mg/kg astaxanthin.

4 . The method of claim 3 , wherein said krill oil comprises from about 3% to 10% ether phospholipids on a w/w basis, so that the total amount of ether phospholipids and non-ether phospholipids in the composition is from about 48% to 60% on a w/w basis.

5 . The method of claim 4 , wherein said krill oil comprises from about 25% to 30% omega-3 fatty acids as a percentage of total fatty acids and wherein from about 80% to 90% of said omega-3 fatty acids are attached to said phospholipids.

6 . The method of claim 5 , wherein said krill oil comprises from about 100 to about 2500 mg/kg astaxanthin.

7 . The method of claim 1 , wherein said omega-3 supplement comprises from about 1% to about 10% w/w ether phospholipids; from about 27% to 50% w/w non-ether phospholipids so that the amount of total phospholipids in the composition is from about 30% to 60% w/w; from about 20% to 50% w/w triglycerides; from about 100 to about 2500 mg/kg astaxanthin; and from about 20% to 35% omega-3 fatty acids as a percentage of total fatty acids in said composition, wherein from about 70% to 95% of said omega-3 fatty acids are attached to said phospholipids.

8 . The method of claim 1 , wherein said omega-3 is selected from EPA and DHA and combinations thereof.

9 . The method of claim 1 , wherein said subject is an adolescent.

10 . The method of claim 9 , wherein said adolescent is a male.

11 . The method of claim 1 , wherein said administration is oral.

12 . The method of claim 1 , wherein said omega-3 phospholipid supplemented is administered a daily dosage of from about 3 grams to about 6 grams per day.

13 . The method of claim 12 , wherein said daily dose is administered in two doses of from 1.5 to 3 grams in the morning and evening.

14 . The method of claim 1 , wherein said subject has been diagnosed with ADHD.

15 . The method of claim 1 , wherein said brain maturation age is calculated by comparison of EEG measurements with reference EEG measurements.

16 . A method of improving or supporting brain maturity age in a subject in need thereof comprising:

administering a krill oil supplement to said subject under conditions such that the brain maturity age of the subject is improved, wherein said krill oil supplement comprises from about 35% to 60% phospholipids on a w/w basis, from about 20% to 45% triglycerides on a w/w basis, and from about 50 to about 2500 mg/kg astaxanthin, and wherein said brain maturation age is calculated by comparison of EEG measurements with reference EEG measurements.

17 . The method of claim 16 , wherein said subject is an adolescent male.

18 . The method of claim 16 , wherein said administration is oral.

19 . The method of claim 16 , wherein said omega-3 phospholipid supplemented is administered a daily dosage of from about 3 grams to about 6 grams per day.

20 . The method of claim 19 , wherein said daily dose is administered in two doses of from 1.5 to 3 grams in the morning and evening.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2016
From: AKER BIOMARINE AS
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 038168/0928 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2016
From: BERGE, KJETIL; BURRI, LENA
To: AKER BIOMARINE AS
Reel/Frame 038122/0372 →